The Column Group Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 12

Professionals

  • Investments
  • 116

  • Portfolio
  • 23

  • Exits
  • 28

Exits

The Column Group General Information

Company Description

Founded in 2007, The Column Group is a venture capital firm based in San Francisco, California. The firm prefers to invest in seed-stage and early-stage companies operating in healthcare, life sciences, oncology, drug discovery, and technology-based sectors in the United States. This firm is a Registered Investment Adviser (RIA).

Business Details

Year Founded
2007
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • 1 Letterman Drive, Building D
  • Suite DM-900
  • San Francisco, CA 94129
  • United States
+1 (415) 000-0000

The Column Group Investments (116)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
NGM Biopharmaceuticals 17-Jul-2024 PE Growth/Expansion 00000 Drug Discovery Generating Revenue/Not Profitable 00000 0000000000
InduPro 13-Jun-2024 00000 00000 0000 Biotechnology Pre-Clinical Trials 00000 00000000 00.0
NGM Biopharmaceuticals 05-Apr-2024 0000000000 00000 Drug Discovery Generating Revenue/Not Profitable 00000 0000000 00.0
Kenai Therapeutics 26-Feb-2024 00000 00000 000.00 Biotechnology Pre-Clinical Trials 0000000 000000
Neurona Therapeutics 06-Feb-2024 00000 00000 00000 Biotechnology Clinical Trials - Phase 1 00000 0000000 00.0
Remix Therapeutics 03-Jan-2024 00000 00000 0000 Biotechnology Generating Revenue 00000 0000000000
Accent Therapeutics 20-Dec-2023 00000 00000 0000 Biotechnology Pre-Clinical Trials 00000000 00000 00.0
Atavistik Bio 19-Dec-2023 00000 00000 0000 Drug Discovery Generating Revenue 0000 00000 00.0
Kimia Therapeutics 19-Dec-2023 Early Stage VC 0000 Discovery Tools (Healthcare) Generating Revenue 0000000 0000000 00.0
Carmot Therapeutics 25-May-2023 Later Stage VC 00000 Biotechnology Clinical Trials - Phase 2 0000000 0000000 00.0
You’re viewing 10 of 116 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

The Column Group Exits (28)

Company Name Exit Date Exit Type Exit Size
Escient Pharmaceuticals 23-Apr-2024 Merger/Acquisition 00000
Carmot Therapeutics 26-Jan-2024 000000000000000000 00.00
Sagimet Biosciences 14-Jul-2023 000 0000
Effector Therapeutics 25-Aug-2021 0000000 000000 00000
Tenaya Therapeutics 30-Jul-2021 000 00000
Constellation Pharmaceuticals 15-Jul-2021 000000000000000000 00.000
Nurix Therapeutics 05-Mar-2021 000000 0000000000 00000
ORIC Pharmaceuticals 13-Nov-2020 000000 0000000000 00000
Nurix Therapeutics 24-Jul-2020 IPO 00000
Constellation Pharmaceuticals 17-Jun-2020 Public Investment 2nd Offering 00000
You’re viewing 10 of 28 exits. Get the full list »

The Column Group Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore The Column Group‘s full profile, request access.

Request a free trial

The Column Group Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

The Column Group Management, Team & Partners (38)

Name Title Deals Funds Boards Office
James Evangelista Partner & Chief Financial Officer 0 San Francisco, CA
Peter Svennilson Founder & Managing Partner 00 0 0 San Francisco, CA
David Goeddel Ph.D Managing Partner 00 0 0 San Francisco, CA
Robert Tjian Ph.D Discovery Partner 0 0 0 San Francisco, CA
Jeffrey Goater Partner 0 0 San Francisco, CA
You’re viewing 5 of 38 team members. Get the full list »

The Column Group FAQs

  • What is The Column Group?

    Founded in 2007, The Column Group is a venture capital firm based in San Francisco, California.

  • When was The Column Group founded?

    The Column Group was founded in 2007.

  • Who is the founder of The Column Group?

    Peter Svennilson is the founder of The Column Group.

  • Where is The Column Group headquartered?

    The Column Group is headquartered in San Francisco, CA.

  • What is The Column Group's total asset value?

    The Column Group has around 00.00 in total assets under management.

  • How many investments has The Column Group made?

    The Column Group has made 116 investments.

  • What has The Column Group invested in?

    The Column Group has made numerous investments in companies like NGM Biopharmaceuticals, InduPro, and Kenai Therapeutics within the Drug Discovery and Biotechnology industries.

  • What has The Column Group invested in recently?

    The Column Group's latest investment was on 17-Jul-2024 in NGM Biopharmaceuticals, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »